HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Survival after hepatic resection in metastatic colorectal cancer: a population-based study.

AbstractBACKGROUND:
Hepatectomy is the standard of care for patients with colorectal cancer who have isolated hepatic metastases; however, the long-term survival benefits of hepatectomy in this population have not been characterized well outside of case series. For the current study, a population-based database was used to compare the survival of patients with liver metastases from colorectal cancer who did and did not undergo hepatectomy.
METHODS:
Patients aged >or=65 years with incident colorectal cancer who were diagnosed from 1991 to 2001 were identified from the linked Surveillance, Epidemiology, and End Results (SEER)-Medicare database. Liver metastasis diagnoses, colorectal resections, and hepatectomies were identified from hospital, outpatient, and physician-supplier claims. Patients who did not undergo colorectal resection were excluded. Five-year survival from the time of cancer diagnosis was determined by the Kaplan-Meier method. Cox proportional hazards models were used to evaluate survival.
RESULTS:
Among 13,599 patients who were identified with incident colorectal cancer and liver metastases, 7673 patients (56.4%) presented with stage IV disease, and the remaining patients presented with earlier stage disease and developed subsequent metastases. Only 833 patients (6.1%) in the cohort underwent hepatic resection, and their 30-day mortality rate was 4.3%. The 5-year survival was 32.8% among patients who underwent hepatic resection, compared with 10.5% among patients who did not undergo hepatic resection (P < .0001), and better survival was observed in the subset of patients who presented initially with disease in stages I through III. In a Cox model, which was controlled for age, sex, race, comorbidities, and stage at presentation, lack of hepatic resection was associated with a 2.78-fold increased risk of death.
CONCLUSIONS:
Although hepatectomy rates among patients with colorectal cancer were low, hepatic resection was associated with improved survival.
AuthorsLinda C Cummings, Jonathan D Payes, Gregory S Cooper
JournalCancer (Cancer) Vol. 109 Issue 4 Pg. 718-26 (Feb 15 2007) ISSN: 0008-543X [Print] United States
PMID17238180 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Topics
  • Adenocarcinoma (mortality, secondary, surgery)
  • Aged
  • Cohort Studies
  • Colorectal Neoplasms (mortality, pathology, surgery)
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Hepatectomy (mortality)
  • Humans
  • Liver Neoplasms (mortality, secondary, surgery)
  • Male
  • Neoplasm Staging
  • Registries
  • SEER Program
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: